eISSN: 2299-0054
ISSN: 1895-4588
Videosurgery and Other Miniinvasive Techniques
Current issue Archive Videoforum Manuscripts accepted About the journal Supplements Abstracting and indexing Subscription Contact Instructions for authors
SCImago Journal & Country Rank


3/2018
vol. 13
 
Share:
Share:
more
 
 
abstract:
Original paper

Short- and long-term results of laparoscopic adrenalectomy for Conn’s syndrome

Mateusz Wierdak, Grzegorz Sokołowski, Michał Natkaniec, Karolina Morawiec-Sławek, Piotr Małczak, Piotr Major, Alicja Hubalewska-Dydejczyk, Andrzej Budzyński, Michał Pędziwiatr

Videosurgery Miniinv 2018; 13 (3): 292–298
Online publish date: 2018/04/03
View full text
Get citation
ENW
EndNote
BIB
JabRef, Mendeley
RIS
Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
 
Introduction
The primary treatment of Conn’s syndrome (CS) is laparoscopic adrenalectomy and aims to normalize arterial blood pressure and biochemical parameters.

Aim
To analyse short- and long-term results of laparoscopic adrenalectomy for Conn’s syndrome (CS).

Material and methods
The analysis included 44 consecutive patients, who underwent laparoscopic adrenalectomy between 2004 and 2015 for CS. We analysed short- and long-terms results of operations. All patients were followed up 6 and 24 months after surgery to determine changes in the biochemical parameters, and clinical regression of arterial hypertension. We also evaluated the aldosteronoma resolution score (ARS) in predicting the resolution of hypertension.

Results
No conversions were needed. Complications occurred in 5 (11.4%) patients. Preoperative hypokalaemia and hypernatraemia were present in 83.4% and 15.8% of patients, respectively. After surgery, both hypokalaemia and hypernatraemia resolved in all patients. At the follow-up 6 months after the surgery, only 11.3% of patients had complete remission (CR) of hypertension. In 43.2% of cases we observed partial remission (PR). After 24 months CR was found in 13.6% of patients, 45.5% patients fulfilled criteria for PR, and 29.5% of patients changed the group of remission comparison to the first follow-up visit. Only 50% of patients with an ARS of 4 or 5 points achieved CR 6 months after surgery.

Conclusions
Laparoscopic adrenalectomy is a safe method of treatment for CS. Although it effectively eliminates electrolyte imbalance, it does not allow for the CR of hypertension in the majority of patients, especially in the elderly group. We did not find ARS to be an effective tool in predicting postoperative resolution of hypertension.

keywords:

laparoscopic adrenalectomy, adenoma, adrenal tumour, long-term outcomes, Conn’s syndrome, aldosteronoma

references:
Hannemann A, Wallaschofski H. Prevalence of primary aldosteronism in patient’s cohorts and in population-based studies: a review of the current literature. Horm Metab Res 2012; 44: 157-62.
Smith CD, Weber CJ, Amerson JR. Laparoscopic adrenalectomy: new gold standard. World J Surg 1999; 23: 389-96.
Pędziwiatr M, Wierdak M, Ostachowski M, et al. Single center outcomes of laparoscopic transperitoneal lateral adrenalectomy – lessons learned after 500 cases: a retrospective cohort study. Int J Surg 2015; 20: 88-94.
Budzyński A, Pędziwiatr M, Matłok M, et al. Preliminary experience with transperitoneal single incision laparoscopic surgery adrenalectomy. Videosurgery Miniinv 2010; 5: 87-92.
Herd A, Harman R, Taylor E. Surgical outcomes following laparoscopic adrenalectomy for treatment of Conn’s syndrome (primary hyperaldosteronism) between 1999 and 2006. N Z Med J 2010; 123: 50-6.
Pang TC, Bambach C, Monaghan JC, et al. Outcomes of laparoscopic adrenalectomy for hyperaldosteronism. ANZ J Surg 2007; 77: 768-73.
Sywak M, Pasieka JL. Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism. Br J Surg 2002; 89: 1587-93.
Funder JW, Carey RM, Mantero F, et al. The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2016; 101: 1889-916.
Natkaniec M, Pędziwiatr M, Wierdak M. Laparoscopic adrenalectomy for pheochromocytoma is more difficult compared to other adrenal tumors. Videosurgery Miniinv 2015; 10: 466-71.
Major P, Matłok M, Pędziwiatr M, et al. Do we really need routine drainage after laparoscopic adrenalectomy and splenectomy? Videosurgery Miniinv 2011; 7: 33-9.
Zarnegar R, Young WF Jr, Lee J, et al. The aldosteronoma resolution score: predicting complete resolution of hypertension after adrenalectomy for aldosteronoma. Ann Surg 2008; 247: 511-8.
Conn JW. Primary aldosteronism. J Lab Clin Med 1955; 45: 661-4.
Douma S, Petidis K, Doumas M, et al. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet 2008; 371: 1921-6.
Strauch B, Zelinka T, Hampf M, et al. Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region. J Hum Hypertens 2003; 17: 349-52.
Wu VC, Wang SM, Chang CH, et al. Long term outcome of Aldosteronism after target treatments. Sci Rep 2016; 6: 32103.
Reimel B, Zanocco K, Russo MJ, et al. The management of aldosterone-producing adrenal adenomas: does adrenalectomy increase costs? Surgery 2010; 148: 1178-85.
Catena C, Colussi G, Lapenna R, et al. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension 2007; 50: 911-8.
Goh BK, Tan YH, Yip SK, et al. Outcome of patients undergoing laparoscopic adrenalectomy for primary hyperaldosteronism. JSLS 2004; 8: 320-5.
Meria P, Kempf BF, Hermieu JF, et al. Laparoscopic management of primary hyperaldosteronism: clinical experience with 212 cases. J Urol 2003; 169: 32-5.
Kokorak L, Soltes M, Vladovic P, Marko L. Laparoscopic left and right adrenalectomy from an anterior approach – is there any difference? Outcomes in 176 consecutive patients. Videosurgery Miniinv 2016; 11: 268-73.
Iacobone M, Citton M, Viel G, et al. Approach to the surgical management of primary aldosteronism. Gland Surg 2015; 4: 69-81.
Citton M, Viel G, Rossi GP, et al. Outcome of surgical treatment of primary aldosteronism. Langenbecks Arch Surg 2015; 400: 325-31.
Jiang SB, Guo XD, Wang HB, et al. A retrospective study of laparoscopic unilateral adrenalectomy for primary hyperaldosteronism caused by unilateral adrenal hyperplasia. Int Urol Nephrol 2014; 46: 1283-8.
Aronova A, Gordon BL, Finnerty BM, et al. Aldosteronoma resolution score predicts long-term resolution of hypertension. Surgery 2014; 156: 1387-92.
Luther JM. Aldosterone in vascular and metabolic dysfunction. Curr Opin Nephrol Hypertens 2016; 25: 16-21.
Sawka AM, Young WF, Thompson GB, et al. Primary aldosteronism: factors associated with normalization of blood pressure after surgery. Ann Intern Med 2001; 135 (4): 258-61.
Utsumi T, Kawamura K, Imamoto T, et al. High predictive accuracy of Aldosteronoma Resolution Score in Japanese patients with aldosterone-producing adenoma. Surgery 2012; 151: 437-43.
Pasquier L, Kirouani M, Fanget F, et al. Assessment of the aldosteronoma resolution score as a predictive resolution score of hypertension after adrenalectomy for aldosteronoma in French patients. Langenbecks Arch Surg 2017; 402: 309-14.
Utsumi T, Kamiya N, Endo T, et al. Development of a novel nomogram to predict hypertension cure after laparoscopic adrenalectomy in patients with primary aldosteronism. World J Surg 2014; 38: 2640-4.
Williams TA, Lenders JWM, Mulatero P, et al. Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort. Lancet Diabetes Endocrinol 2017; 5: 689-99.
  
Quick links
© 2018 Termedia Sp. z o.o. All rights reserved.
Developed by Bentus.
PayU - płatności internetowe